ERA Impact on the Life Sciences Industry of a Change in
the UK Relationship with the EU
Tim Wilsdon

Impact on the Life Sciences Industry of a Change in
the UK Relationship with the EU

The e-presentation offers a prospective analysis of the positive and negative impacts of Brexit for the EU and for the UK on the life sciences value chain from research to market access of pharmaceutical products. The different political scenarios which could be adopted after Brexit, as well as the future of EMA and NICE, are also discussed.

Tim Wilsdon

Free version

This version of the e-presentation shows the complete e-presentation.

No certificate can be provided for using this version.
 
 

Start

Premium version

The premium version offers free navigation, downloadable slides, MP3 version, offline video version and the seminars background documentation as additional value.

It is also eligble for the acquisition of CPD points.

Buy